121 related articles for article (PubMed ID: 17613754)
1. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
Roman-Gomez J; Jimenez-Velasco A; Barrios M; Prosper F; Heiniger A; Torres A; Agirre X
Leuk Lymphoma; 2007 Jul; 48(7):1269-82. PubMed ID: 17613754
[TBL] [Abstract][Full Text] [Related]
2. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.
Roman-Gomez J; Jimenez-Velasco A; Castillejo JA; Agirre X; Barrios M; Navarro G; Molina FJ; Calasanz MJ; Prosper F; Heiniger A; Torres A
Blood; 2004 Oct; 104(8):2492-8. PubMed ID: 15198948
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
[TBL] [Abstract][Full Text] [Related]
6. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
[TBL] [Abstract][Full Text] [Related]
10. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
[TBL] [Abstract][Full Text] [Related]
11. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
12. 5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia.
Roman-Gomez J; Castillejo JA; Jimenez A; Gonzalez MG; Moreno F; Rodriguez Mdel C; Barrios M; Maldonado J; Torres A
Blood; 2002 Apr; 99(7):2291-6. PubMed ID: 11895758
[TBL] [Abstract][Full Text] [Related]
13. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
[TBL] [Abstract][Full Text] [Related]
15. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
17. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
Schäfer V; Ernst J; Rinke J; Winkelmann N; Beck JF; Hochhaus A; Gruhn B; Ernst T
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1641-50. PubMed ID: 27169594
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
[TBL] [Abstract][Full Text] [Related]
19. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
[TBL] [Abstract][Full Text] [Related]
20. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
